[
  {
    "ts": "2025-11-22T12:11:58+00:00",
    "headline": "West Pharmaceutical Services (WST): Gauging Valuation After Q3 Beat, Raised Guidance, and Bullish Market Momentum",
    "summary": "West Pharmaceutical Services reported third-quarter results that outperformed expectations, with organic growth driving a 7.7% year-over-year increase in net sales. The company also raised its full-year guidance, supporting recent gains in the stock price. See our latest analysis for West Pharmaceutical Services. West Pharmaceutical’s recent 5.2% one-day share price jump came on the heels of strong quarterly results, a raised outlook, and a dose of positive macro sentiment around potential...",
    "url": "https://finance.yahoo.com/news/west-pharmaceutical-services-wst-gauging-121158497.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "b8a16aca-500d-377c-b63c-956852e0d791",
      "content": {
        "id": "b8a16aca-500d-377c-b63c-956852e0d791",
        "contentType": "STORY",
        "title": "West Pharmaceutical Services (WST): Gauging Valuation After Q3 Beat, Raised Guidance, and Bullish Market Momentum",
        "description": "",
        "summary": "West Pharmaceutical Services reported third-quarter results that outperformed expectations, with organic growth driving a 7.7% year-over-year increase in net sales. The company also raised its full-year guidance, supporting recent gains in the stock price. See our latest analysis for West Pharmaceutical Services. West Pharmaceutical’s recent 5.2% one-day share price jump came on the heels of strong quarterly results, a raised outlook, and a dose of positive macro sentiment around potential...",
        "pubDate": "2025-11-22T12:11:58Z",
        "displayTime": "2025-11-22T12:11:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4G9ppBeYPHN150Vf7ljszA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rJ2VkF_7pHDs8.rNQqRscw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/west-pharmaceutical-services-wst-gauging-121158497.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/west-pharmaceutical-services-wst-gauging-121158497.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-22T11:14:39+00:00",
    "headline": "What Catalysts Could Shift the Narrative for West Pharma After Analyst Upgrades and New Guidance",
    "summary": "West Pharmaceutical Services' stock narrative has seen little change in its fair value price target, which remains steady at $350.77 following recent analysis. Analysts cite strong quarterly results and stable company prospects as key reasons for this consistency. Market opinions vary from bullish optimism to cautious watchfulness. Stay tuned to see how you can keep informed on future shifts in West Pharmaceutical's evolving market story. Stay updated as the Fair Value for West Pharmaceutical...",
    "url": "https://finance.yahoo.com/news/catalysts-could-shift-narrative-west-111439905.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "b7f108a7-6bcb-31d0-8ee6-8b5f536bb1ab",
      "content": {
        "id": "b7f108a7-6bcb-31d0-8ee6-8b5f536bb1ab",
        "contentType": "STORY",
        "title": "What Catalysts Could Shift the Narrative for West Pharma After Analyst Upgrades and New Guidance",
        "description": "",
        "summary": "West Pharmaceutical Services' stock narrative has seen little change in its fair value price target, which remains steady at $350.77 following recent analysis. Analysts cite strong quarterly results and stable company prospects as key reasons for this consistency. Market opinions vary from bullish optimism to cautious watchfulness. Stay tuned to see how you can keep informed on future shifts in West Pharmaceutical's evolving market story. Stay updated as the Fair Value for West Pharmaceutical...",
        "pubDate": "2025-11-22T11:14:39Z",
        "displayTime": "2025-11-22T11:14:39Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4G9ppBeYPHN150Vf7ljszA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rJ2VkF_7pHDs8.rNQqRscw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/catalysts-could-shift-narrative-west-111439905.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/catalysts-could-shift-narrative-west-111439905.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]